Treating Metastatic TNBC: Where Are We Now?
Medscape,
Treating triple-negative breast cancer (TNBC), one of the more lethal breast cancer subtypes, remains a challenge.
Treating triple-negative breast cancer (TNBC), one of the more lethal breast cancer subtypes, remains a challenge.
Treating triple-negative breast cancer (TNBC), one of the more lethal breast cancer subtypes, remains a challenge.
In March 2019, the Food and Drug Administration (FDA) issued an accelerated approval for the immune checkpoint inhibitor…